19/04/2014 08:51:23 Free Membership Login

Alliance Pharma Company Financial Information

 Company name: Alliance Pharma
 EPIC: APH Trading Currency: GBX
 Market Sector: AIM ISIN: GB0031030819
 Market Segment: AIM Share Type: DE
 WWW Address:  Description: ORD 1P
 Industry Sector: PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Ask Open High Low Volume
 33.75 mages.advfn.com/imagesnew/2/us/dot 0.0 [0.00] 33.50 34.00 33.75 33.75 33.75 17,644
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 89.15 264.14 0.59 3.82 0.91 8.84 2.70 40.50 - 31.00

Alliance Pharma Key Figures

(at previous day's close)
Market Cap.89.15m
Shares In Issue264.14m
Prev. Close33.75
PE Ratio8.84 
Dividend Yield2.70%
EPS - basic3.82p
Dividend PS0.91p
Dividend Cover4.20 
Cash Flow PS3.80p
Return On Equity (ROE)14.82%
Operating Margin26.39%
PEG Factor1.52 
EPS Growth Rate5.82%
Dividends PS Growth Rate9.64%
Net Debt41.44m
Gross Gearing39.56%
Quick Assets11.43m
Net Working Capital1.95m
Intangibles / Fixed Assets98.85%
Turnover PS17.23p
Pre-Tax Profit PS4.55p
Retained Profit PS2.86p
Cash PS0.34p
Net Cash PS-5.32p
Net Tangible Asset Value PS *-9.23p
Net Asset Value PS24.48p
Spread0.50 (1.47%) 

Alliance Pharma Balance Sheet

LSE:APH:Liabilities+EQLSE:APH:Assets

Alliance Pharma Share Price

Sample Period HighLow
1 week33.7533.50
4 weeks34.5033.00
12 weeks35.2531.75
1 year40.5031.00

Alliance Pharma Share Price (5 years)

Alliance Pharma Historic Returns

Giorni da oggi OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week33.630.130.3733.750.1633.75
4 weeks33.250.501.5033.860.4633.85
12 weeks32.880.882.6633.580.3133.60
26 weeks35.63-1.88-5.2634.940.3134.68
1 year36.00-2.25-6.2535.140.2934.90
3 years36.38-2.63-7.2231.720.2631.67
5 years9.1324.63269.8630.040.3430.36

Alliance Pharma Key Management Ratios

Alliance Pharma Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio56.38 
PE Ratio8.84 
Tobin's Q Ratio 0.86 
Tobin's Q Ratio (excl. intangibles)4.61 
Dividend Yield2.70%
Market-to-Book Ratio1.38 
Price-to-Pre-Tax Profit PS7.42 
Price-to-Retained Profit PS11.82 
Price-to-Cash Flow PS8.89 
Price-to-Sales PS1.96 
Price-to-Net Tangible Asset Value PS-3.65 
Price-to-Cash PS100.39 
Net Working Capital PS0.74 
Price Pct to Working Capital PS45.81%
Earnings Yield11.32%
Average PE9.39 
Years in average5 
PE to PE average94.12%

Alliance Pharma Financial Ratios

(Leverage Ratios)
Debt Ratio29.74%
Debt-to-Equity Ratio0.42 
Debt-to-Equity Ratio (excl. Intgbl)-1.12 
Debt-to-Equity Market Value0.31 
Net Gearing38.73%
Net Gearing (excl. Intangibles)231.09%
Gross Gearing39.56%
Gross Gearing (excl. Intangibles)236.05%
Gearing Under 1 Year13.97%
Gearing Under 1 Year (excl. Intgbl)83.37%
Assets/Equity1.65 
Cash/Equity1.37 
(Liquidity Ratios)
Net Working Capital to Total Assets1.82%
Current Ratio1.13 
Quick Ratio (Acid Test)0.76 
Liquidity Ratio0.06 
Cash & Equiv/Current Assets5.26%
(Solvency Ratios)
Enterprise Value115.63m
CFO/Sales0.22 
CFO/Attributable Profit1.05 
CFO/Assets0.09 
CFO/Debt0.24 
Total Debt/Equity Market Value0.47 
Total Debt/Sales0.93 
Total Debt/Pre-Tax Profit3.52 
Total Debt42.32m
Total Debt/Net Current Assets21.75%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth1.81%
5 yr Compound Earnings Growth10.02%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs4 
Beta (60-Mnth)Beta (36-Mnth)
0.5935-0.1273
Alpha (60-Mnth)Alpha (36-Mnth)
0.02100.0040

Alliance Pharma Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)13.05%
Return On Assets (ROA)9.23%
Net Profit Margin21.06%
Assets Turnover0.44 
Return On Equity (ROE)14.82%
Return On Investment (ROI)11.23%
Dividend Payout Ratio23.82%
Plowback Ratio76.18%
Growth from Plowback Ratio12.53%
Net Income Of Revenues16.58%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.78 
Fixed Assets Turnover0.53 
Current Assets Turnover2.46 
Net Working Capital Turnover 
Inventory Turnover8.38 
(Other Operating Ratios)
Total Assets-to-Sales2.28 
Debtors-to-Sales22.72%
Debt Collection Period82.94Days

Alliance Pharma Dividends

Announcement DateTypeCurr.Dividend AmountPeriod StartPeriod EndEx DateRecord DatePayment DateTotal Dividend Amount
26 Mar 2014FinalGBX0.6112/31/201212/31/201306/11/201406/13/201407/10/20140.91
11 Sep 2013InterimGBX0.3012/31/201212/31/201312/04/201312/06/201301/15/2014-
21 Mar 2013FinalGBX0.5512/31/201112/31/201206/12/201306/14/201307/11/20130.83
12 Sep 2012InterimGBX0.2812/31/201112/31/201212/05/201212/07/201201/15/2013-
22 Mar 2012FinalGBX0.5012/31/201012/31/201106/13/201206/15/201207/12/20120.75
07 Sep 2011InterimGBX0.2512/31/201012/31/201111/30/201112/02/201101/13/2012-
23 Mar 2011FinalGBX0.4012/31/200912/31/201006/15/201106/17/201107/14/20110.57
08 Sep 2010InterimGBX0.1712/31/200912/31/201012/01/201012/03/201001/14/2011-
24 Mar 2010FinalGBX0.2312/31/200812/31/200906/16/201006/18/201007/15/20100.30
09 Sep 2009InterimGBX0.0712/30/200806/30/200912/02/200912/04/200901/15/2010-

Alliance Pharma Fundamentals

 31 Dec 2010 (GBP)31 Dec 2011 (GBP)31 Dec 2012 (GBP)31 Dec 2013 (GBP)
turnover49.88100.00%45.96100.00%44.90100.00%45.51100.00%m
pre tax profit12.8725.81%10.7123.31%10.8124.08%12.0126.39%m
attributable profit8.9517.95%8.6418.79%8.6919.36%9.5821.06%m
retained profit8.2916.61%7.2815.83%6.8915.34%7.5416.58%m
eps - basic3.96 3.62 3.61 3.82 
eps - diluted3.64 3.39 3.40 3.68 
dividends per share0.57 0.75 0.83 0.91 

Alliance Pharma Balance Sheet

 31 Dec 2010 (GBP)31 Dec 2011 (GBP)31 Dec 2012 (GBP)31 Dec 2013 (GBP)
LSE:APH:Liabilities+EQLSE:APH:AssetsLSE:APH:Liabilities+EQLSE:APH:AssetsLSE:APH:Liabilities+EQLSE:APH:AssetsLSE:APH:Liabilities+EQLSE:APH:Assets
 31 Dec 2010 (GBP)31 Dec 2011 (GBP)31 Dec 2012 (GBP)31 Dec 2013 (GBP)
ASSETS
fixed assets fixed assets0.891.15%0.770.93%0.560.56%0.590.55%m
intangibles intangibles60.2977.89%66.1380.37%79.8979.39%89.0683.24%m
fixed investments fixed investments--%--%--%0.440.41%m
current assets - other current assets - other--%--%--%--%m
stocks stocks4.545.87%5.656.87%5.395.36%5.475.11%m
debtors debtors9.6912.52%8.6610.52%10.1510.08%10.549.85%m
cash & securities cash & securities1.992.57%1.081.31%4.634.61%0.890.83%m
TOTAL77.40100%82.29100%100.63100%106.99100%m
LIABILITIES
creditors - short creditors - short16.9821.94%13.8616.84%22.0521.91%14.9513.97%m
creditors - long creditors - long24.3431.45%24.3029.53%26.7326.57%27.3725.59%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL41.3253.38%38.1646.37%48.7848.47%42.3239.56%m
EQUITY
ord cap, reserves ord cap, reserves36.0846.62%44.1353.63%51.8551.53%64.6760.44%m
prefs, minorities prefs, minorities--%--%--%--%m
TOTAL36.0846.62%44.1353.63%51.8551.53%64.6760.44%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Alliance Pharma Cash Flow Statement

31 Dec 2010 (GBP)31 Dec 2011 (GBP)31 Dec 2012 (GBP)31 Dec 2013 (GBP)
Operating CF16.8110.1612.4410.03m
Pre-Financing CF1.601.32-0.560.12m
Retained CF1.60-0.883.53-5.80m

Alliance Pharma Brokers

NameActivityTypeMnemonicCode
Evolution Securities LimitedMarket Maker(MMF)Broker/DealerEVOEVBGGB21MMT
Numis Securities LimitedMarket Maker(MMF)Broker/DealerNUMSRAZHGB2LBIC
Shore Capital Stockbrokers LtdMarket Maker(MMF)Broker/DealerSCAPSHOCGB21
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC



NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us lse aph140419 08:51